An Analysis of 3-Year Outcomes Following Canaloplasty for the Treatment of Open-Angle Glaucoma
Purpose. To report 3-year results investigating the safety and efficacy of canaloplasty for open-angle glaucoma. Setting. University of Oklahoma, Dean McGee Eye Institute, Oklahoma, United States of America. Design. Nonrandomized single-center retrospective chart review. Methods. Adult open-angle gl...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2017-01-01
|
| Series: | Journal of Ophthalmology |
| Online Access: | http://dx.doi.org/10.1155/2017/2904272 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832564080171286528 |
|---|---|
| author | Mahmoud A. Khaimi Justin D. Dvorak Kai Ding |
| author_facet | Mahmoud A. Khaimi Justin D. Dvorak Kai Ding |
| author_sort | Mahmoud A. Khaimi |
| collection | DOAJ |
| description | Purpose. To report 3-year results investigating the safety and efficacy of canaloplasty for open-angle glaucoma. Setting. University of Oklahoma, Dean McGee Eye Institute, Oklahoma, United States of America. Design. Nonrandomized single-center retrospective chart review. Methods. Adult open-angle glaucoma eyes underwent canaloplasty or combined cataract-canaloplasty surgery. A tensioning suture was placed into Schlemm’s canal in all eyes. Primary endpoints included the mean IOP and mean number of glaucoma medications at each follow-up visit. Secondary endpoints included visual acuity and surgical/postsurgical complications. Results. The study cohort included 277 eyes (mean age, 72.8 years). Overall, the mean baseline IOP of 19.7 mmHg was reduced to 14.3 mmHg,14.0 mmHg, and 15.2 mmHg at 1, 2, and 3 years, respectively (p<0.001). The average medicine use was reduced from 2.1 preoperatively to 0.4 at 12 months, and 0.5 and 0.6 at two and three years, respectively (p<0.001). The frequency of surgical and postsurgical complications was low with no serious adverse events recorded. Conclusion. Canaloplasty was safe and effective in achieving long-term IOP reductions and reduced dependence on antiglaucoma medications. |
| format | Article |
| id | doaj-art-b9054bc7abe642fcbec8cb0a3092b991 |
| institution | Kabale University |
| issn | 2090-004X 2090-0058 |
| language | English |
| publishDate | 2017-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Ophthalmology |
| spelling | doaj-art-b9054bc7abe642fcbec8cb0a3092b9912025-02-03T01:11:53ZengWileyJournal of Ophthalmology2090-004X2090-00582017-01-01201710.1155/2017/29042722904272An Analysis of 3-Year Outcomes Following Canaloplasty for the Treatment of Open-Angle GlaucomaMahmoud A. Khaimi0Justin D. Dvorak1Kai Ding2Dean McGee Eye Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USADepartment of Biostatistics and Epidemiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USADepartment of Biostatistics and Epidemiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USAPurpose. To report 3-year results investigating the safety and efficacy of canaloplasty for open-angle glaucoma. Setting. University of Oklahoma, Dean McGee Eye Institute, Oklahoma, United States of America. Design. Nonrandomized single-center retrospective chart review. Methods. Adult open-angle glaucoma eyes underwent canaloplasty or combined cataract-canaloplasty surgery. A tensioning suture was placed into Schlemm’s canal in all eyes. Primary endpoints included the mean IOP and mean number of glaucoma medications at each follow-up visit. Secondary endpoints included visual acuity and surgical/postsurgical complications. Results. The study cohort included 277 eyes (mean age, 72.8 years). Overall, the mean baseline IOP of 19.7 mmHg was reduced to 14.3 mmHg,14.0 mmHg, and 15.2 mmHg at 1, 2, and 3 years, respectively (p<0.001). The average medicine use was reduced from 2.1 preoperatively to 0.4 at 12 months, and 0.5 and 0.6 at two and three years, respectively (p<0.001). The frequency of surgical and postsurgical complications was low with no serious adverse events recorded. Conclusion. Canaloplasty was safe and effective in achieving long-term IOP reductions and reduced dependence on antiglaucoma medications.http://dx.doi.org/10.1155/2017/2904272 |
| spellingShingle | Mahmoud A. Khaimi Justin D. Dvorak Kai Ding An Analysis of 3-Year Outcomes Following Canaloplasty for the Treatment of Open-Angle Glaucoma Journal of Ophthalmology |
| title | An Analysis of 3-Year Outcomes Following Canaloplasty for the Treatment of Open-Angle Glaucoma |
| title_full | An Analysis of 3-Year Outcomes Following Canaloplasty for the Treatment of Open-Angle Glaucoma |
| title_fullStr | An Analysis of 3-Year Outcomes Following Canaloplasty for the Treatment of Open-Angle Glaucoma |
| title_full_unstemmed | An Analysis of 3-Year Outcomes Following Canaloplasty for the Treatment of Open-Angle Glaucoma |
| title_short | An Analysis of 3-Year Outcomes Following Canaloplasty for the Treatment of Open-Angle Glaucoma |
| title_sort | analysis of 3 year outcomes following canaloplasty for the treatment of open angle glaucoma |
| url | http://dx.doi.org/10.1155/2017/2904272 |
| work_keys_str_mv | AT mahmoudakhaimi ananalysisof3yearoutcomesfollowingcanaloplastyforthetreatmentofopenangleglaucoma AT justinddvorak ananalysisof3yearoutcomesfollowingcanaloplastyforthetreatmentofopenangleglaucoma AT kaiding ananalysisof3yearoutcomesfollowingcanaloplastyforthetreatmentofopenangleglaucoma AT mahmoudakhaimi analysisof3yearoutcomesfollowingcanaloplastyforthetreatmentofopenangleglaucoma AT justinddvorak analysisof3yearoutcomesfollowingcanaloplastyforthetreatmentofopenangleglaucoma AT kaiding analysisof3yearoutcomesfollowingcanaloplastyforthetreatmentofopenangleglaucoma |